Alkermes (ALKS) Tops Q3 EPS by 26c, Updates FY Guidance

Alkermes (NASDAQ: ALKS) reported Q3 EPS of $0.26, $0.26 better than the analyst estimate of $0.00. Revenue for the quarter came in at $265 million versus the consensus estimate of $237.94 million.

GUIDANCE:

Alkermes sees FY2020 EPS of $0.31-$0.43, versus the consensus of $0.10. Alkermes sees FY2020 revenue of $1.01-1.035 billion, versus the consensus of $982.45 billion.

For earnings history and earnings-related data on Alkermes (ALKS) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Cosmos Health posts 31% revenue gain in Q2 and H1 2026
• TRNR agrees to acquire STEPR, raises 2026 revenue guidance to $50M